Search

everythinglearnresearchcommunity

for

Search:↓

Hormone levels change during puberty, leading to physical developments like pubic hair and voice changes.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Scalp hair 17-OHP and androstenedione levels can help monitor treatment in CAH patients.

Androstenedione, a hormone supplement, doesn't improve muscle or performance and can cause harmful side effects.

The chemicals 17βC and its methyl ester can block the effects of testosterone on hamster skin but not the effects of DHT.

A model using hormone levels, cycle length, and BMI can help identify PCOS in Chinese women but isn't for screening teens.

The new method makes finasteride cheaper and easier to produce.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

A new method was developed to make a compound used in finasteride and epristeride with a 69% yield.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Spironolactone reduced hair thickness and some testosterone levels in women with excessive hair growth.

Long-term use of finasteride in women can cause hormonal changes, DNA damage, and menstrual issues.

Insulin changes sex hormone levels in women with polycystic ovary syndrome without affecting other hormone releases.

Sebocytes play a key role in controlling androgen levels in human skin.

During puberty, hormone levels rise, with early increases in some steroids and most menstrual cycles becoming regular by six years after menarche.

Sickle cell anemia causes hormone issues and delayed puberty due to testicular failure.

Finasteride safely lowers DHT levels without affecting testosterone.

A new method accurately measures long-term steroid levels in human hair.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

The ovary mainly causes high testosterone in PCO, while the adrenal gland is the main source in IH.

17α-estradiol boosts aromatase activity in female hair follicles, potentially helping with hair loss.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

Dexamethasone effectively normalizes elevated steroid levels in girls with premature adrenarche.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Leuprolide plus estrogen is more effective than oral contraceptives for reducing hirsutism.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.